0001891257-22-000002.txt : 20220112
0001891257-22-000002.hdr.sgml : 20220112
20220112162023
ACCESSION NUMBER: 0001891257-22-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220110
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Girolamo Todd C
CENTRAL INDEX KEY: 0001891257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33650
FILM NUMBER: 22526779
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: 2ND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CALADRIUS BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0000320017
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 222343568
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 908-229-2590
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: Caladrius Biosciences, Inc.
DATE OF NAME CHANGE: 20150608
FORMER COMPANY:
FORMER CONFORMED NAME: NeoStem, Inc.
DATE OF NAME CHANGE: 20060906
FORMER COMPANY:
FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE
DATE OF NAME CHANGE: 20030819
4
1
wf-form4_164202240462407.xml
FORM 4
X0306
4
2022-01-10
0
0000320017
CALADRIUS BIOSCIENCES, INC.
CLBS
0001891257
Girolamo Todd C
C/O CALADRIUS BIOSCIENCES, INC.
110 ALLEN ROAD, 2ND FLOOR
BASKING RIDGE
NJ
07920
0
1
0
0
CLO, SVP of Corp Dev
Common Stock
2022-01-10
4
A
0
129000
0
A
187675
D
Common Stock
2022-01-10
4
F
0
17405
0.917
D
170270
D
Common Stock
2022-01-11
4
F
0
4722
0.8651
D
165548
D
Stock Option (Right to Buy)
0.917
2022-01-10
4
A
0
65000
0
A
2022-01-10
2032-01-10
Common Stock
65000.0
65000
D
Represents 129,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
Includes 136,500 unvested restricted stock.
Shares withheld as payment of a tax liability on vesting of restricted stock.
Includes 127,750 unvested restricted stock.
One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
Todd C. Girolamo
2022-01-12